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Abstract
Rift Valley fever virus (RVFV) is a mosquito-borne virus in the family Bunyaviridiae that has spread throughout continental
Africa to Madagascar and the Arabian Peninsula. The establishment of RVFV in North America would have serious
consequences for human and animal health in addition to a significant economic impact on the livestock industry.
Published and unpublished data on RVFV vector competence, vertebrate host competence, and mosquito feeding patterns
from the United States were combined to quantitatively implicate mosquito vectors and vertebrate hosts that may be
important to RVFV transmission in the United States. A viremia-vector competence relationship based on published
mosquito transmission studies was used to calculate a vertebrate host competence index which was then combined with
mosquito blood feeding patterns to approximate the vector and vertebrate amplification fraction, defined as the relative
contribution of the mosquito or vertebrate host to pathogen transmission. Results implicate several Aedes spp. mosquitoes
and vertebrates in the order Artiodactyla as important hosts for RVFV transmission in the U.S. Moreover, this study identifies
critical gaps in knowledge which would be necessary to complete a comprehensive analysis identifying the different
contributions of mosquitoes and vertebrates to potential RVFV transmission in the U.S. Future research should focus on (1)
the dose-dependent relationship between viremic exposure and the subsequent infectiousness of key mosquito species, (2)
evaluation of vertebrate host competence for RVFV among North American mammal species, with particular emphasis on
the order Artiodactyla, and (3) identification of areas with a high risk for RVFV introduction so data on local vector and host
populations can help generate geographically appropriate amplification fraction estimates.
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Introduction
Rift Valley fever virus (RVFV) is an emerging infectious disease
in Africa and the Middle East. If introduced to North America,
RVFV is capable of serious health and socioeconomic conse-
quences potentially incapacitating large numbers of humans,
decimating susceptible farm animals, and instigating heavy
restrictions on livestock trade [1,2]. Although transmission of the
virus can occur through aerosol inhalation or direct tissue-tissue
contact by handling of infected organisms, an enzootic cycle
between mosquito vectors and domestic or wild animals has been
repeatedly proposed as a main mechanism of transmission [3].
Clinical signs vary by vertebrate species and age, but infected
pregnant ruminants generally suffer spontaneous abortions and
juvenile ruminants suffer high mortality while occasional spillover
into human populations results in a self-limiting, febrile illness that
may progress to encephalitis, retinitis, blindness, hemorrhagic
fever or death [2–5]. In 1931, RVFV was first reported in Kenya.
It spread to Egypt in 1977 and was detected on the Arabian
Peninsula in 2000 [6,7]. Since advancing beyond African borders
in 2000, total human cases of RVFV include 768 confirmed
fatalities, 4,248 confirmed infections and over 75,000 suggested
unconfirmed cases [8–15].
The emergence of arthropod-borne viruses (arboviruses)
through geographic expansion is facilitated when amplification
hosts include wild or domestic animals, as demonstrated by West
Nile virus (WNV), Japanese encephalitis, and epizootic hemor-
rhagic disease [2,16]. Aedes and Culex spp. mosquitoes are
proposed to be the main vectors of RVFV, where Aedes spp. act as
the reservoir and maintenance vectors that emerge after flood
events and feed heavily on livestock [17]. Culex spp. mosquitoes
then become involved as amplifying hosts of RVFV leading to
epizootics and the eventual spillover to human populations [5,17–
19]. However, the understanding of RVFV transmission biology in
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Africa and the Arabian Peninsula remains underdeveloped.
Additionally, unresolved questions surround endemic persistence
of the virus, such as transovarial transmission [17].
Should RVFV arrive, diagnosing the disease and controlling the
spread of infected vertebrates will take time, and proactive
management plans should be created to minimize the time to
react and break transmission of the pathogen. Even though RVFV
is identified as an emerging infectious disease threat and is
classified as a ‘‘Category A select agent’’ by both the Centers for
Disease Control and Prevention and the US Department of
Agriculture, gaps in data are preventing a proper evaluation of the
different roles vectors and vertebrate hosts potentially may play in
RVFV transmission in the U.S. beyond qualitative conjecture
[1,20]. To prepare for an arbovirus introduction, it is essential to
understand which vectors and vertebrate hosts may be responsible
for viral amplification and transmission, as disease control methods
vary depending on the target species [21,22]. For example,
mosquito species using small container habitats for larval
development are often controlled using larvicides and source
reduction of aquatic habitat, whereas mosquito species with
synchronous emergence following flooding events are controlled
by adulticides or granular larvicides applied prior to flooding
[23,24].
To assess the role of mosquitoes and hosts in the transmission of
a virus, it is important to quantify the ability for a mosquito species
to transmit a pathogen (vector competence), the infectiousness of
vertebrate host species (host competence), and contact rates
between mosquitoes and vertebrate hosts. In the WNV system,
Kilpatrick et al. [25] combined data on vector competence,
abundance, and mosquito feeding patterns to identify the species
of mosquitoes responsible for bridge transmission of WNV to
humans. Several studies have then implicated important avian
hosts disproportionately responsible for WNV amplification based
on mosquito host feeding patterns, mosquito vector competence
data, and vertebrate host competence data [26,27]. By applying
models utilized in the WNV system, we can implicate potentially
important vectors and vertebrate hosts in RVFV transmission
should the virus arrive. A number of reviews discuss potential
vertebrate hosts, disease vectors, and environments that may
support RVFV transmission in the U.S., through environmental
receptivity models [28] and spatial overlap of important host
populations [22]. However, to our knowledge, no study has
quantitatively evaluated the theoretical importance of different
mosquito species and vertebrate hosts to RVFV transmission and
amplification in the U.S. [28].
This study utilized published and unpublished vector and host
competence data and mosquito feeding patterns to model the
theoretical roles of different mosquito and vertebrate species in the
amplification and transmission of RVFV in the U.S. Although
predictions from this analysis are strictly theoretical, and limited by
available data, these results highlight critical gaps in knowledge
necessary to properly evaluate the potential transmission activity of
RVFV in the U.S. and provide hypotheses that can support
proactive arbovirus surveillance and control programs.
Methods
Vector competence
Mosquito vector competence studies evaluate the ability of
mosquitoes to develop an infection and ultimately transmit the
pathogen during feeding. Data generated from vector competence
studies include viral dissemination and transmission rates. Viral
dissemination rates are defined as the percentage of orally exposed
mosquitoes with virus detected in their legs seven or more days
after RVFV infection. Transmission rates are defined as the
percentage of orally exposed mosquitoes (regardless of infection
status) that transmitted virus by bite upon refeeding [21]. Selected
studies evaluated mosquito species that occur in the U.S. and
monitored dissemination and transmission rates after feeding on a
RVFV infected animal at the incubation temperature of 26uC.
RVFV vector competence studies were located using Web of
Science, NCBI’s Pubmed, and the Armed Forces Pest Manage-
ment Board Literature Retrieval Systems [21,29–35].
Analyzing viral dissemination and transmission data drawn
from multiple studies is problematic because these data are
dependent on the viremic titer of exposure [33] and the compiled
transmission data for this analysis reflects mosquitoes exposed to
viremia that ranged from 104.3 to 1010.2 plaque-forming units/ml
(PFU/ml). To address this issue, a regression analysis of log
viremia versus experimental transmission data from 17 mosquito
species (Figure S1, A and B) was utilized to estimate the
dependence of dissemination and transmission rates on viremic
dose. Slopes from these regressions were combined with experi-
mental data from each mosquito species to interpolate what the
dissemination and transmission rates would be at the exposure
viremia of 107.5 PFU/ml (equations shown in Table S1). Mosquito
species that demonstrated low overall vector competence in
experimental transmission studies due to midgut escape barriers or
salivary gland barriers (i.e. Anopheles crucians (Wiedemann), Cx.
nigripalpus (Theobald) and Ae. infirmatus (Dyar & Knob)) or had
a limited sample size (N,2 mosquitoes) were not used in the
regression analyses [29].
The viremia-dissemination equation was equal to 0.098*(Log10
viremia) 20.268 and the viremia-transmission rate of a mosquito
with a disseminated infection equation was equal to 0.056*(Log10
viremia)20.0155 (Figure S1, A and B; Table S1). Both equations
show a positive relationship for dissemination (N= 27; R2= 0.28;
p = 0.0049) and transmission (N= 27; R2= 0.13; p = 0.07) as
viremic dose increases. For each mosquito species we generated a
linear equation and the y-intercept was adjusted for each mosquito
species based on the difference between the experimentally
observed rate and what the standardized equations described
Author Summary
In anticipation of continued pathogen emergence in the
U.S. due to globalization climate change, and other factors,
the development of proactive management plans and
interventions to predict and then intervene is going to be
more efficient and effective than retrospective plans
developed after pathogen emergence. Effective manage-
ment of mosquito-borne pathogens like Rift Valley fever
virus (RVFV) requires an understanding of the roles that
different mosquito species and vertebrate hosts play in
transmission. This study combines data on mosquito
transmission efficiency, mosquito feeding patterns, and
vertebrate infectiousness to quantitatively evaluate the
relative importance of different mosquito species and
vertebrate hosts to the amplification of RVFV in the U.S.
We identify several species of floodwater Aedes spp.
mosquitoes that would be the most likely vectors for
RVFV, and hoofed ungulates (deer, cows, sheep) would be
the most important amplifying vertebrate hosts. Although
these data provide public and animal health agencies a
priori knowledge on the primary mosquitoes that should
be targeted for vector control and the highest priority
animals to receive vaccines, this analysis reveals many gaps
in knowledge reducing our ability to predict and then
manage a potential invasion of RVFV.
Predicting Transmission of Rift Valley Fever Virus in United States
PLOS Neglected Tropical Diseases | www.plosntds.org 2 September 2014 | Volume 8 | Issue 9 | e3163
above (Figure S1, A and B) would predict at a specific viremic
dose. This adjusted y-intercept and the standardized slopes from
Figure S1, A and B (Dissemination m=0.098, Transmission
m=0.056) were utilized to create two unique linear equations for
each mosquito species: one to calculate dissemination rate and one
to calculate transmission rate with respect to viremic dose for each
vector species. By solving for y when x= log10 7.5 PFU/ml we
were able to estimate dissemination and transmission rates at an
exposure viremia of 107.5 PFU/ml for each mosquito species
(Table 1, Table S1). When there were multiple data points for a
mosquito species the averages of exposure viremia and the
observed experimental transmission data were used to calculate
the two linear equations for vector competence standardization.
Additional data points were estimated that describe transmis-
sion rates for Ae. dorsalis (Meigen), Cx. erythrothorax (Dyar), Cx.
tarsalis, and Cx. erraticus (Dyar-Knab) mosquitoes that developed
a disseminated infection based on the estimated transmission rates
of Turell et al. [32]. These data were standardized with the same
methodology described above. Vector competence (Cv) was
calculated by multiplying the fraction of mosquitoes that develop
a disseminated infection after feeding on a viremic host by the
transmission rate of mosquitoes with disseminated infection based
on estimated values for an exposure viremia of 107.5 PFU/ml [36].
Vertebrate host competence
When mosquitoes feed on an infected vertebrate a fraction of
those mosquitoes will become infectious depending on the
intensity of the vertebrate host’s viremia and the mosquito’s
susceptibility to the virus [37]. Experimental infection studies that
exposed vertebrate species to RVFV and monitored post-infection
viremias were used to create a host competence index (Ci). The
vertebrate reservoir competence index represents the relative
number of infectious mosquitoes that may result from feeding on
infected vertebrate hosts and is calculated as the product of
susceptibility to infection, mean daily infectiousness to each species
of mosquito, and duration of infectiousness [38]. Published studies
were located using Web of Science, NCBI’s Pubmed, and the
Armed Forces Pest Management Board Literature Retrieval
Systems. Studies utilizing PFU/ml and Tissue Culture Infectious
Dose 50% (TCID50) techniques to quantify viral titers after
experimental infection with virulent strains of RVFV
(ZH501,T1,T46, AN1830, Kabete, 80612A, AnD100286,
Table 1. Estimated dissemination rate, transmission rate, and vector competence for mosquitoes exposed to 7.5 log PFU/ml Rift
Valley fever virus.
Species [citation] Dissemination ratea Transmission rateb Vector Competence (Cv)c
Coquillettidia perturbans [29] 0.53 0.72 0.38
Aedes j. japonicus [30] 0.74 0.51 0.37
Culex tarsalis [31,32] 0.38 0.87 0.33
Aedes excrucians [31] 0.28 1.00 0.28
Aedes canadensis [31] 0.70 0.40 0.28
Aedes sollicitans [31] 0.76 0.34 0.25
Aedes triseriatus [31] 0.75 0.32 0.24
Psorophora ferox [29] 0.55 0.32 0.18
Culex territans [31] 0.39 0.45 0.17
Aedes atlanticus [29] 0.36 0.42 0.15
Aedes taeniorhynchus [21,31] 0.49 0.27 0.13
Aedes albopictus [33] 0.52 0.25 0.13
Culex salinarius [31] 0.54 0.24 0.13
Culex pipiens [32,34,35] 0.13 0.90 0.12
Aedes vexans [21,29] 0.26 0.41 0.11
Aedes aegypti [34] 0.70 0.11 0.08
Aedes cantator [31] 0.71 0.11 0.07
Mansonia dyari [29] 0.17 0.40 0.07
Culex erythrothorax [32] 0.17 0.26 0.04
Culex erraticus [32] 0.15 0.28 0.04
Culex nigripalpus [21,29,32] 0.06 0.24 0.01
Anopheles bradleyi-crucians [31] 0.17 0.05 0.01
Aedes infirmatus [29] 0.29 0.00 ,0.01
Anopheles crucians [29] ,0.01 ,0.01 ,0.01
Culex quinquefasciatus [32,34] ,0.01 0.14 ,0.01
Aedes dorsalis [30] 0.32 ,0.01 ,0.01
aAverage rate of mosquitoes, regardless of infection status, containing virus in their legs.
bAverage rate of refeeding mosquitoes with a disseminated infection that transmitted virus.
cAverage rate of disseminated infection after ingesting RVFV multiplied by percentage of mosquitoes with a disseminated infection that transmitted virus by bite.
doi:10.1371/journal.pntd.0003163.t001
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AnD100287, Z8548, FRhL2) were the only inclusion criteria for
host competence data as no universal conversion between Lethal
Dose 50% (LD50) and Mouse Lethal Dose 50% (MLD50) was
found. Conversion from TCID50 to PFU/ml was obtained by the
equation: PFU/ml =TCID50/ml60.69 [39,40].
To calculate the vertebrate host competence index for RVFV,
an equation describing vector competence was calculated utilizing
available mosquito transmission experiments performed at 26uC as
a linear function of log (host viremia). This viremia-vector
competence equation (Figure S1, C) describes the fraction of
mosquitoes that would become infected after feeding on a single
viremic host indicating the infectiousness of a vertebrate [37,38].
Because of limited species-specific experimental transmission
data, the viremia-vector competence equation is based on the
combined experimental transmission data of 17 mosquito species
(See Figure S1). Mosquito species that demonstrated low overall
vector competence in experimental transmission studies due to
midgut escape barriers or salivary gland barriers or had a limited
sample size as described above were not used to calculate the
viremia-vector competence relationship [29]. The viremia-vector
competence equation (vector competence = 0.062 (Log10 viremia)
20.276; R2 = 0.27; N= 27; P =,0.001) was used to calculate the
daily infectiousness of vertebrate hosts by inserting daily
vertebrate host viremia titers into the equation. When the
equation calculated a vertebrate host’s infectiousness to be
negative the vertebrate host’s daily infectiousness was set to zero
[37]. These daily values were summed over the host’s viremic
period and used as the vertebrate species’ competence index (Ci).
When multiple experimental studies existed for a particular
vertebrate species or taxonomic group a mean Ci was calculated
[37,38,41].
Vector amplification fraction
To determine the theoretical importance of a mosquito to
RVFV transmission it is important to consider contact rates
between vectors and vertebrate hosts. The amplification fraction
estimates the number of infectious mosquitoes resulting from
feeding on a particular host and can be utilized as an index to
compare the relative role of various vectors in transmission. In the
WNV system, the relative number of infectious (transmitting)
mosquito vectors resulting from feeding on a vertebrate host was
estimated by Kent et al. [42] utilizing the following equation:
Fi=Bi
2 * Ci where Fi= the relative number of infectious
mosquitoes resulting from feeding on each vertebrate species i,
where Bi= the proportion of blood meals from species i and
Ci= reservoir competence. This equation was modified from
Kilpatrick et al. [43] which estimated the fraction of WNV-
infectious mosquitoes, Fi, resulting from feeding on each avian
species, i, as the product of the relative abundance, the vertebrate
reservoir competence index, Ci, and the mosquito forage ratio.
Kent et al. [42] found that the relative abundance of each avian
species cancelled out when multiplied by the forage ratio, of which
the denominator is relative abundance. Fi as defined by Kilpatrick
et al. [43] was therefore reduced to the product of Ci and the
proportion of blood meals from species i. Because the viremia-
vector competence relationship used in this analysis is based on
data from multiple mosquito species, Kent et al’s [42] Fi equation
was modified to multiply by the mosquito’s vector competence
value (Cv) to account for the differences observed in mosquito
vector transmission competence across species. The modified
equation is referred to as the vector amplification fraction (Fvi) and
provides a theoretical means to compare the role of various vector
species in the transmission of RVFV.
Fvi~Bi
2  Ci  Cv
In the Fvi equation, the number of infectious mosquitoes
resulting from feeding on a vertebrate host, Fvi, is equal to
vertebrate host competence (Ci), multiplied by the vector
competence (Cv), multiplied by the fraction of the total blood
meals from host i squared (Bi
2) [27,42]. Bi represents the number
of blood meals taken from a vertebrate host species divided by the
total blood meals taken. Bi is unique to each mosquito species and
is used as an indicator of exposure to RVFV and as an indicator of
potential RVFV-infectious bites received by a host species, or
taxonomic group [44]. Mosquito host feeding data from 39 studies
were combined to generate a robust estimate of mosquito feeding
patterns at the taxonomic resolution of Class and Order compiled
into Table S2. Vertebrate hosts fed on by mosquitoes lacking a
competence index (Ci) were assigned the closest taxonomic mean
[41]. Only mosquito species with over 40 recorded blood meals to
calculate vertebrate host feeding proportions (Bi) were included in
this analysis. When vector competence data were missing for a
given mosquito species, vector competence values were substituted
based on the taxonomic subgenus average (Aedes- Ochlerotatus:
0.15; Culex- Melanoconion: 0.04, Culex: 0.11), genus average
(Anopheles: ,0.01; Psorophora: 0.18, Mansonia: 0.07) or family
average (Culicidae: 0.15). To include Ae. aegypti in this analysis
host-feeding patterns were estimated based on mosquito feeding
patterns in Puerto Rico [45].
Fvi is unique to each mosquito vector-vertebrate host pair and
assumes initial seroprevalence, susceptibility and competence
values are equal among all adult and juvenile vertebrate hosts
[27,46–47]. In an attempt to control any effect of the exposure
dose of RVFV on the outcome of mosquito transmission
competency, the Fvi calculation only utilized mosquito compe-
tence values standardized to an exposure dose of 107.5 PFU/ml as
described above. To calculate a mosquito species’ vector
amplification fraction resulting from feeding on all vertebrate
hosts, all Fvi values reflecting a vector-vertebrate pair were
summed for each mosquito species (equations shown in Table S3).
This overall risk for a mosquito species to contribute to RVFV
transmission in the U.S. was calculated based on a weighted
percentage relative to the total Fvi displayed by all mosquitoes.
Vertebrate host amplification fraction
To explore the theoretical contribution of vertebrates to RVFV
amplification and transmission in the U.S., Fvi values unique to
each vector-vertebrate pair described above were summed across
each vertebrate host instead of by mosquito vector. The resulting
index expresses the relative number of infectious mosquitoes
generated by each vertebrate host. Since species-specific compe-
tence data was lacking for all vector-vertebrate host contacts, the
role of vertebrate hosts was explored at the taxonomic resolution
of class, order, and family. By summing Fvi values with respect to
vertebrate host at different taxonomic levels we were able to
quantify the theoretical amplification fraction displayed by each
vertebrate host taxonomic group. This index was expressed as a
weighted average by dividing the summed Fvi values for a
vertebrate group by the total Fvi value calculated for the
mammalian order (Table S3).
Results
Vector competence
Eight experimental studies were identified that fit the inclusion
criteria for this analysis [21,29–35]. Data for 26 mosquito species
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were adjusted utilizing the viremic dose-dependent relationship of
dissemination and transmission rates based on 17 species of
mosquitoes (Figure S1, A and B). Standardized dissemination and
transmission values were multiplied together to calculate vector
competence (Table 1 and S1). The most competent transmission
vectors of RVFV when exposed to 107.5 PFU/ml of viremia are
estimated to be Coquillettidia perturbans (Walker) (0.38), Ae.
japonicus japonicus (Theobald) (0.37), Cx. tarsalis (0.33), and Ae.
excrucians (0.28). Some mosquito species were estimated to be
incompetent for RVFV, such as An. crucians (,0.01), Ae.
infirmatus (,0.01), and Cx. quinquefasciatus (Say) (,0.01)
(Table 1).
Host competence
To estimate vertebrate host competence, published data and
unpublished data provided by Dr. John Morrill from RVFV
experimental infections (Figure 1) [39,40,48–65] were inserted
into a viremia-vector competence equation that describes the
relative number of infectious mosquitoes resulting from feeding on
a vertebrate host (Figure S1, C). Exposure viremia dosages ranged
from 104.3–10.2 PFU/ml at an incubation temperature of 26uC.
With this approach, 12 vertebrate species demonstrated reservoir
competence by producing sufficient viremia titers to infect
mosquitoes after exposure to RVFV, all of which were mammals
(Figure 2) [38–40]. Vertebrate host species demonstrating com-
petence for viral amplification were the following: sheep (Ovis
aries, Class Artiodactyla), domestic cow (Bos taurus, Artiodactyla),
domestic goat (Capra aegagrus hircus, Artiodactyla), mouse (Mus
musculus, Rodentia); brown rat (Rattus norvegicus, Rodentia), the
common marmoset (Callithrix jacchus, Primates); four-striped
grass mouse (Rhabdomys pumilio, Rodentia); South African
pouched mouse (Saccostomus campestris, Rodentia); Rhesus
macaque (Macaca mulatta, Primates); Griselda’s striped grass
mouse (Lemniscomys griselda, Rodentia); African buffalo (Syncerus
caffer, Artiodactyla); and namaqua rock rat (Aethomys namaquen-
sis, Rodentia). Many species were considered incompetent because
they did not develop a sufficient viremia profile to infect mosquito
vectors (#104.7 PFU/ml), such as the red rock rat (Aethomys
chrysophilus, Rodentia), African grass rat (Arvicanthis niloticus,
Rodentia), guniea multimammate mouse (Mastomys erythroleucus,
Rodentia), natal multimammate mouse (Mastomys natalensis,
Rodentia), Mongolian gerbil (Meriones unguiculatus, Rodentia),
Atlantic canary (Serinus canaria, Passeriformes), domestic chick-
ens (Gallus gallus, Galliformes) and the Bushveld gerbil (Taera
leucogaster, Rodentia).
The vertebrate host competence index averages based on
taxonomy were the following: Class: Mammalian (0.17), Aves
(0.00); Order: Primates (0.25), Artiodactyla (0.21), Rodentia (0.05);
Family: Bovidae (0.21), Muridae (0.05), Cricitidae (0.05); Genus:
Ovis (0.29), Bos (0.19), Capra (0.15), Rattus (0.04).
Vector amplification fraction
Among mosquito species evaluated, the vector amplification
fraction (SFvi) ranged from 0 to 0.018 (Table 2). The resulting
index was expressed as a weighted percentage relative to the total
amplification fraction demonstrated by the 40 mosquito species
included in this analysis, which ranged from 0% to 11.7%
(Table 2; See Table S3 for calculations). This index estimates the
relative probability that a mosquito will feed on an infectious
vertebrate host, develop a disseminated infection into the salivary
glands, and ultimately transmit RVFV to a vertebrate host during
a subsequent blood-feeding event. Mosquito species with the
highest amplification fractions were: Ae. japonicus japonicus
(Theobald) (11.4%), Ae. thibaulti (Dyar and Knab) (8.8%), Ae.
canadensis (Theobald) (7.4%), Culiseta inornata (Williston) (6.7%),
Wyeomyia mitchellii (Theobald) (6.6%), Ae. sollicitans (Walker)
(5.4%), Cq. perturbans (5.4%), Ae. sticticus (Meigen) (5.4%), Ae.
aegypti (5.0%) and Ae. nigromaculis (Ludlow) (4.4%) (Table 2).
Vertebrate host amplification fraction
Overall four classes (Mammalia, Aves, Amphibia, and Reptilia),
eight mammalian orders (Artiodactyla, Carnivora, Chiroptera,
Didelphimorpha, Lagomorpha, Perissodactyla, Primates, Roden-
tia), six families (Bovidae, Cervidae, Cricitidae, Muridae, Sciur-
idae, Suidae) and seven genera (Bos, Capra, Dama, Homo,
Odocoilius, Ovis, Rattus) of vertebrates were included in the
model. As indicated by vertebrate competence studies, only
mammals are competent hosts and are estimated to contribute
100% of theoretical RVFV amplification in the U.S. The order
Artiodactyla is estimated to contribute 64.3% of all theoretical
mammalian RVFV amplification followed by the orders Lago-
morpha (16.8%), Primates (6.8%), Carnivora (4.4%), Rodentia
(0.8%), Perissodactyla (0.4%), Didelphimorpha (0.1%), and
Chiroptera (0.0%) (Table S3). Because some blood meal data
was only specific to the taxonomic resolution of Class there were
undefined mammalian hosts that represent 6.3% of the risk, which
means all % risk estimates are potentially underestimated (Table
S3). Similarly, within the Artiodactyla order 10.5% risk is
undefined, therefore, the family Cervidae accounts for at least
56% of the theoretical RVFV amplification contributed to
Artiodactyla, while Bovidae contributes 34%, and Suidae
contributes ,1% (Table S3).
Discussion
Vector competence
Rift Valley fever virus has been isolated from at least 40 African
mosquito species and currently 19 North American species have
been shown to be competent laboratory vectors of RVFV, several
of which are known vectors of enzootic viruses of large mammals
(e.g., Cx. tarsalis and western equine encephalitis virus or Ae.
taeniorhynchus (Wiedemann) and Venezuelan equine encephali-
tis). These data suggest that a suite of mosquito vectors could
potentially transmit RVFV should the virus reach North America
[21].
Overall, results from previous studies have indicated that vector
competence for RVFV is variable between mosquito species and
among different populations of the same mosquito species. These
variations in vector competence within mosquito species could be
due to differences in development temperatures, phenotype, or
parasite interactions that facilitate or block viral transmission
[25,32,66–68]. Viral infection, dissemination and transmission
rates are also dependent on the titer of the viremic exposure [33].
Because mosquito control methods vary for different mosquito
species, future RVFV transmission experiments are necessary to
better understand variations in vector competence [32,68].
Vertebrate host competence
The vertebrate host competence index value depends on the
viral titer circulating in the blood and the duration of this
infectious viremia [38]. As the classic RVFV transmission
paradigm would hypothesize, which implicates peri-domestic
livestock as important amplification hosts, the calculated verte-
brate host competence index shows sheep, domestic cow, domestic
goat, and African buffalo may potentially contribute to RVFV
amplification (Figure 2) [69]. Primates from the new world also
demonstrate a high competence suggesting humans may play a
role in RVFV transmission. In the 1977 Egyptian outbreak of
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RVFV, Meegan et al. [6] demonstrated that humans produce a
viremia of 10 4.1–10 8.6 LD50, but how this relates to vertebrate
competence values of new world monkeys remains unclear. The
vertebrate competence index indicates rodents can be competent
amplification hosts, but their role in viral amplification may be
limited as mosquitoes rarely use them as blood meal hosts. The
lack of RVFV competence for parakeets, canaries, and pigeons
has been described, however our analysis of the class Aves was
limited to a study evaluating the Atlantic canary (S. canaria) [52]
and an unpublished study by Turell et al. evaluating domestic
chickens (G. gallus), both of which have a competence index of
zero.
It is apparent that RVFV viremia profiles vary between
vertebrate hosts (Figure 1 and Figure 2). These variations empha-
size the importance of characterizing RVFV viremia profiles of
domestic and wild animals present in the U.S., especially since
their immune systems may be more susceptible to a foreign virus.
Experimental infection studies evaluating vertebrate species from
the U.S. with larger sample sizes will manifest in more accurate
competence values and provide a finer set of data to better
implicate important vertebrate hosts for RVFV amplification
should the pathogen emerge in the U.S.
Vector amplification fraction
Previous experimental transmission studies conclude that Cx.
tarsalis and Ae. j. japonicus are the most competent vectors with
the highest risk to transmit RVFV should it arrive in the U.S.;
however, vector competence does not directly imply a significant
role in disease transmission [21,30–33,36,68]. The vector ampli-
fication fraction provides a means to quantitatively compare
theoretical risk of various mosquito species based on their potential
to contribute to RVFV transmission in the U.S. Vector-host
contact rates, as dictated by mosquito feeding patterns, is a key
component to consider when evaluating the risk of a mosquito
vector, as illustrated by the Cx. tarsalis mosquioto. Cx. tarsalis is
one of the most competent vectors of RVFV in the U.S. (Table 1),
which feeds mainly on avian hosts (Table S2), and therefore, is
predicted to have a low amplification fraction in comparison to
other vectors as seen in Table 2 (0.2% of total risk). Recent
transmission experiments by Turell et al. [30] suggest that Ae. j.
japonicus mosquitoes are the most competent vector of RVFV in
the U.S. (previously Cx. tarsalis). The vector amplification fraction
calculated in this study further implicates Ae. j. japonicus as a high
risk vector with the potential to contribute to RVFV transmission
in the U.S. (11.4%, Table 2). This invasive mosquito has a high
Figure 1. A graphical representation of the mean viremia profiles demonstrated by 20 different vertebrates after exposure to
virulent strains of Rift Valley fever virus. Data was compiled from 17 published experimental infection studies and unpublished data from Dr.
John Morrill and Dr. Michael Turell. Viral titers were quantified each day after infection by Plaque Assay or Tissue Culture Infectious Dose 50, which
was converted to PFU/ml by the following equation: PFU/ml = TCID50/ml60.69 [39,40]. When a vertebrate host’s viremia was calculated to be
negative the daily infectiousness was set to zero as discussed in the methodology. References: Bovids: [48–51]; Birds: [52] (Turell unpublished data);
Primate: [53–55] (Morrill unpublished data); Rodent: [56–65].
doi:10.1371/journal.pntd.0003163.g001
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vector competence (0.37, Table 1), feeds heavily on competent
hosts (Artiodactyla 80% and Primates 16%, Table S1), and is
found in all U.S. states east of the Mississippi river except for
Florida and Louisiana [70]. Should RVFV spread to the U.S., Ae.
j. japonicus populations should be carefully monitored for
infection and potentially targeted for mosquito control [30].
Ae. sticticus and Cs. inornata both demonstrate varying degrees
of transmission competency, but vector competence for these two
species remains undetermined. In the study by Iranpour [68],
RVFV was detected in the saliva of Ae. sticticus after experimental
infection and Cs. inornata demonstrated both a high infection rate
(100%; N=5) and high dissemination rate after exposure to
RVFV viremia between 107.9 to 109.4 PFU/ml (60%; N=3).
Considering both these species feed heavily on the order
Artiodactyla (Ae. sticticus 94% and Cs. inornata 80%, Table S2)
their role in RVFV transmission in the U.S. is uncertain and
should be evaluated. Ae. trivittatus is another mammal-biting
mosquito estimated to have a moderate role in transmission that
occurs in large populations in the Eastern U.S. and is lacking
experimental data.
Among the top 10 mosquito species theoretically contributing to
RVFV transmission in the U.S., only five species (Ae. j. japonicus,
Ae. sollicitans, Ae. canadensis, Cq. perturbans and Ae. aegypti)
have data comprehensive enough for this analysis. This under-
scores the lack in data necessary to estimate the theoretical role of
different mosquito vectors in RVFV transmission in the U.S. Of
those ranking as high-risk for contributing to RVFV enzootic
transmission, some are limited in geographic range within the U.S.
(e.g. Wy. mitchellii) underscoring the importance for including
spatial and temporal mosquito abundance data while evaluating
local regions for RVFV transmission potential. These results
indicate a gap in experimental transmission data and requisite
further vector competence evaluations to properly evaluate the
potential risk of mosquitoes contributing to RVFV transmission in
the U.S. Future studies should pay particular emphasis on
assessing and re-evaluating the regional transmission competence
and population dynamics of Ae. j. japonicus, Cs. inornata, Ae.
sollicitans, Ae. sticticus (only 13 individuals have been evaluated
[70]), Ae. nigromaculis (all data from one study in 1988 [31]), and
Ae. trivittatus because of their estimated risk and abundance in the
Eastern U.S.
Vertebrate host amplification fraction
Artiodactyla, Lagomorpha, Primates, and Carnivora are
estimated to be theoretically involved in RVFV amplification in
the U.S., while the Mammalian orders Perissodactyla, Didelphi-
morpha and Chiroptera are not (Table S3). The order Chiroptera
may deserve further investigation as a potential reservoir host as
RVFV has been isolated from several bat genera [71] and even
though antibodies against RVFV have been detected in horses, the
family Equidae has demonstrated low viremic titers [72,73].
Our results suggest that Artiodactyla contributes 64.3% of the
theoretical risk for RVFV transmission in the U.S., which supports
the currently held paradigm that Artiodactyla are the most
important vertebrate host for RVFV amplification and transmis-
sion. Research and control efforts should place a particular
emphasis on the families Cervidae and Bovidae as they account for
at least 56% and 34% of the total risk contributed by the order
Artiodactyla, respectively (Table S3). Based on the 2012 Census of
Agriculture (USDA National Agriculture Statistics Service) there
are about 90 million cattle, 5 million sheep, 3 million goats, and
300,000 captive cervids. There are an estimated 25 million white-
tailed deer (Odocoileus virginianus) in the U.S. [74]. Throughout
the U.S. captive and wild ruminants are widely available and
heavily utilized by mosquitoes (Table S2) emphasizing their
potential role in RVFV transmission.
It is important to note that the role of the order Lagomorpha
(17%) may be inflated by the vector amplification fraction because
their estimated vertebrate competence was based on a mammalian
average (0.17). No studies provide evidence supporting that
Lagomorphs are capable of producing an infectious viremia, but
little research has evaluated their role in RVFV ecology [52].
Similarly, vertebrate competence of the order Carnivora is lacking.
Studies demonstrate susceptibility in cats, dogs, ferrets and
serological studies demonstrate antibodies against RVFV in lions
(Panthera leo) and the polecat (Ictonyx striatus) [72,75–77].
Experimental evaluation within the Order Carnivora should focus
on the competence of dogs, cats, and raccoons because mosquito
host-feeding is mainly associated with these species (Table S2).
Figure 2. Rift Valley fever virus host competence index values
for 20 vertebrate hosts based on experimental infection
studies characterizing viremia profiles in PFU/ml or TCID50.
The vertebrate host competence index value depends on the viral titer
circulating in the blood and the duration of the infectious viremia [38].
Each value represents the sum of daily probabilities that an infected
vertebrate host will transmit RVFV to a biting mosquito. This value was
obtained by inserting the recorded daily viremia of experimentally
infected hosts into the viremia-vector competence equation [%
infectious = 0.062 (Log10 viremia)20.276 (R
2 = 0.27; p,0.001; N= 27)]
(Figure S1, C). When a vertebrate host’s viremia was calculated to be
negative the daily infectiousness was set to zero. Conversion from
TCID50 to PFU/ml was obtained by the equation: PFU/ml = TCID50/
ml60.69 [39,40]. *Denotes a vertebrate species found in the U.S.
doi:10.1371/journal.pntd.0003163.g002
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Table 2. Relative risk of mosquitoes contributing to Rift Valley fever enzootic transmission in the U.S.
Mosquito Species Vector Competence (Cv)
a (SFvi)
b % Riskc
Aedes japonicus japonicus 0.37 3.10E-02 11.42%
Aedes thibaulti 0.15` 2.30E-02 8.80%
Aedes canadensis 0.28 2.00E-02 7.42%
Culiseta inornata 0.15e 1.80E-02 6.75%
Wyeomyia mitchellii 0.15e 1.80E-02 6.63%
Aedes sollicitans 0.25 1.50E-02 5.37%
Coquillettidia perturbans 0.38 1.50E-02 5.36%
Aedes sticticus 0.15` 1.40E-02 5.40%
Aedes aegypti 0.08 1.30E-02 5.04%
Aedes nigromaculis 0.15` 1.20E-02 4.46%
Aedes cantator 0.07 9.60E-03 3.34%
Psorophora columbiae 0.18{ 8.70E-03 3.25%
Aedes trivittatus 0.15` 8.30E-03 3.12%
Aedes fulvus pallens 0.15` 8.10E-03 3.04%
Aedes taeniorhynchus 0.13 7.80E-03 2.92%
Psorophora discolor 0.18{ 7.00E-03 2.64%
Psorophora ferox 0.18 6.60E-03 2.49%
Aedes albopictus 0.13 5.90E-03 2.22%
Aedes atlanticus 0.15 5.70E-03 2.10%
Mansonia titillans 0.07{ 4.70E-03 1.78%
Aedes triseriatus 0.24 4.30E-03 1.57%
Aedes vexans 0.11 3.30E-03 1.26%
Culex erythrothorax 0.04 3.10E-03 1.02%
Culex salinarius 0.13 1.90E-03 0.71%
Culex cedecei 0.04` 1.00E-03 0.37%
Deinocerites cancer 0.15e 9.90E-04 0.37%
Culex tarsalis 0.33 5.90E-04 0.22%
Culex erraticus 0.04 5.30E-04 0.19%
Culex stigmatosoma 0.11` 3.70E-04 0.14%
Culex nigripalpus 0.01 3.30E-04 0.09%
Culex restuans 0.11` 2.30E-04 0.09%
Anopheles crucians ,0.01 2.30E-04 0.08%
Anopheles quadrimaculatus ,0.01{ 2.10E-04 0.08%
Anopheles punctipennis ,0.01{ 2.10E-04 0.08%
Culex pipiens 0.12 1.70E-04 0.07%
Culex pilosus 0.04` 1.20E-04 0.05%
Culiseta moristans 0.15e 1.10E-04 0.04%
Aedes infirmatus 0 8.28E-05 0.03%
Culex territans 0.17 4.80E-06 0.00%
Culiseta melanura 0.15e 3.40E-06 0.00%
Culex peccator 0.04` 2.10E-07 0.00%
Aedes dorsalis 0 0.00E+00 0.00%
Culex quinquefasciatus 0 0.00E+00 0.00%
aEstimated Transmission Rate (Cv) (Values from Table 1).
b(SFvi) for each mosquito species where Fi = Bi
2*Ci * Cv.
cSFvi4total Fvi demonstrated by all mosquitoes.
{Genus average (Anopheles: ,0.01; Psorophora: 0.18; Mansonia: 0.07).
`Subgenus average (Aedes- Ochlerotatus: 0.15; Culex: Melanoconion: 0.04, Culex: 0.11).
eFamily average substituted (Culicidae: 0.15).
doi:10.1371/journal.pntd.0003163.t002
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Arbovirus amplification in domestic and peridomestic animals
and eventual spillover to humans is a well-documented phenom-
enon. However the permanent establishment of dengue and
chikungunya viruses in urban, tropical environments demonstrates
the ability for arboviruses to subsist through human reservoirs [2],
especially important given the recent emergence of chikungunya in
the Caribbean in 2013 [76]. The vertebrate amplification fraction
estimates Primates will contribute about 7% of the theoretical
RVFV amplification in the U.S. (Table S3). This estimate is based
on the assumption that the human viremia profile is comparable to
Rhesus macaques and common marmosets. Viremia data from
new-world monkeys as a surrogate for human viremia may
overstate the role of humans in RVFV transmission. In the 1977
Egyptian outbreak of RVFV, Meegan et al. [6] demonstrated that
indeed humans produce a viremia of 10 4.1–10 8.6 LD50, however
socio-economic factors in the U.S. may limit mosquito-human
contact rates, and dampen any role in amplification of RVFV. As
such, the role of humans as vertebrate hosts for RVFV
amplification remains unknown.
Hypotheses implicating rodents as important hosts for RVFV
amplification started when high death rates of Arvicanthis
abyssinicus and Rattus rattus coincided with sheep deaths caused
by RVFV in 1932 [72]. Experimental studies demonstrate rodents
can be competent amplification hosts for RVFV (Figure 1 & 2)
depending on the viremic dose, age, and species [72]. However,
results from the vertebrate amplification fraction suggest members
of the order Rodentia are at low risk for contributing to RVFV
transmission because of infrequent contact with mosquitoes (Table
S2).
Limitations
Given the gaps in data preventing a complete analysis of the
amplification fraction potentially produced by all mosquito and
vertebrate hosts, we made several assumptions that limit the
accuracy of these results. This analysis does not account for spatial
or temporal variation in mosquito abundance or competence, both
of which are known to be spatially heterogeneous and influence
pathogen transmission dynamics [32,77]. Many of the mosquito
species and vertebrate hosts included in the analysis have no
competence data and for these species we assigned taxonomic
averages. It is important to note that taxonomic averages are not
always appropriate and extrapolations based on taxonomic
averages for both vectors and vertebrate hosts can lead to spurious
results (e.g. disparate RVFV vector competence exists for several
Culex spp.) [41]. By combining data on 39 studies reporting
mosquito host-feeding patterns in different regions and landscapes
across the U.S, we aim to incorporate a robust measure of
vertebrate host utilization. However, the mosquito host-feeding
patterns for several species are based on a single study, and given
the importance of host availability [78], a single study might not be
broadly representative of host feeding patterns. Despite these
limitations, the results from this study highlight potentially
important mosquito vectors and vertebrate hosts of RVFV that
should be monitored in the event RVFV emerges in the U.S.
Additionally, this study identifies knowledge gaps that can be filled
by future experimental work on both vectors and vertebrate
species.
Conclusion
World-wide zoonotic disease emergence is an increasing
phenomenon due to environmental changes, ecological distur-
bances, and globalization [79]. The U.S. has already been affected
by the emergence of WNV, recently identified a new zoonotic
disease (Heartland virus) [80,81], and is threatened by the spread
of chikungunya virus to the Caribbean [76]. During the initial
epidemics of WNV in the U.S. in 2002 and 2003, many mosquito
control programs did not have a strong focus on Culex spp.
mosquitoes. As knowledge of the WNV transmission system
increased, vector control has improved by targeting Culex species
to reduce human exposure events. The delay of Culex spp. vector
control might have allowed more human WNV disease and may
have contributed to the rapid spread of the virus across the U.S.
highlighting the importance of a priori response strategies for
potential viral threats.
RVFV is of particular concern in the U.S. because it causes
disease in humans and economically important animals alike.
Even more, its emergence throughout Africa and the Arabian
Peninsula make it a conceivable threat for future geographic
expansion. We combined published data to provide an estimate of
each vector and vertebrate taxon’s contribution to RVFV
amplification in the U.S. However, major gaps in knowledge exist
preventing a comprehensive evaluation of potentially important
vectors and vertebrate hosts to RVFV transmission in the U.S.
Results, combined with information on abundance of vectors and
vertebrate hosts, can provide guidance for proactive management
programs and aid parameterization for further modeling efforts
evaluating environmental receptivity of RVFV in the U.S. [22,28].
Additionally, the framework of this analysis can also be applied to
regions in Africa and the Arabian Peninsula with endemic RVFV
transmission to help identify important vectors and vertebrate
hosts for vector control and vaccination programs.
Future research efforts should focus on: 1) further evaluating the
dose-dependent nature of RVFV vector competence in geograph-
ically widespread mosquitoes quantified as high risk: Ae. j.
japonicus, Ae. canadensis, Cs. inornata, Ae. sollicitans, Cq.
perturbans, Ae. sticticus, Ae. nigromaculis, Ae. cantator and Ae.
trivitattus 2) characterizing local vector competence in high risk
areas for RVFV introduction, and 3) evaluating the RVFV viremia
profiles of vertebrates in the U.S. with particular emphasis on the
orders Artiodactyla (Cervidae, Bovidae, Suidae), Lagomorpha, and
Carnivora (domestic dog, domestic cat, raccoon), respectively.
Supporting Information
Figure S1 Dose-dependent relationship between exposure
viremia and dissemination rate (A), transmission rate (B), and
vector competence (C) displayed by 17 mosquito species in seven
experimental transmission experiments: Ae. aegypti, Ae. albopictus,
Ae. atlanticus, Ae. canadensis, Ae. cantator, Ae. sollicitans, Ae.
taeniorhynchus, Ae. triseriatus, Ae. vexans, Cq. perturbans, Cx.
erraticus, Cx pipiens, Cx. salinarius, Cx. tarsalis, Cx. territans,
Ma. dyari, and Ps. ferox. Studies are cited in main manuscript.
(TIF)
Table S1 To standardize Rift Valley fever virus experimental
transmission data two equations referenced in row 60 that estimate
the viremia dose dependence of dissemination rate and transmis-
sion rate (see Figure S1-A and Figure S1-B) were utilized to
interpolate what the dissemination and transmission rates would
be at the exposure viremia of 107.5 PFU/ml. A species average
was calculated (Columns H and K) and multiplied together to
calculate the vector competence at the same exposure viremia
(Column L).
(XLS)
Table S2 Number and percentage of mosquito blood meals
grouped by vertebrate host class and selected orders. Data is based
on 39 combined mosquito feeding studies across the United States.
(DOCX)
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Table S3 Vector competence data, vertebrate competence data,
and mosquito feeding patterns were combined to estimate the Rift
Valley fever virus amplification fraction displayed by the vectors
and vertebrates in the United States. In the Fvi equation (Fvi=Bi
2
* Ci * Cv), the number of infectious mosquitoes resulting from
feeding on a vertebrate host, Fvi, is equal to vertebrate host
competence (Ci: located in row 5), multiplied by the vector
competence (Cv: located in column C), multiplied by the fraction
of the total blood meals from host i squared (Bi
2: indicated in each
cell as a number divided by total blood meals in column B). All Fvi
values reflecting a vector-vertebrate pair were summed for each
mosquito species (Column AC) and summed for each vertebrate
species (Row 49). To present these values as a % risk (Column AD)
the values of the vector amplification fraction were weighted over
the total amplification demonstrated by all vectors, then multiplied
by 100. To express the vertebrate contribution to RVFV
amplification as a % risk (Row 50), the amplification values at
the taxonomic resolution of Family and Order were weighted over
the total amplification estimated by all mammals (Cell: Y49), then
multiplied by 100. Because some blood meal data was only specific
to the Mammalian class, 6.3% of the estimated amplification
fraction is undetermined at the resolution of Order. Therefore, all
order % risk estimates are minimum estimates.
(XLS)
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